For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 ...

GSK is betting on AI to boost innovation for ... but a balanced approach toward regulation is important, CEO Emma Walmsley says. Speaking at the CEO Times Summit in London, Walmsley highlights ...

It is also eyeing £2 billion plus in sales for HIV pre-exposure prophylaxis ... the bullish view of GSK's pipeline prospects delivered by chief executive Emma Walmsley seemed to strike a chord ...

GSK stock opened at GBX 1,444.50 ($18.15) on Friday. The company has a debt-to-equity ratio of 114.64, a quick ratio of 0.73 and a current ratio of 0.81. GSK plc has a 52 week low of GBX 1,282.50 ...

GSK, led by chief executive Emma Walmsley, has struggled with shares falling almost 20 per cent since 2022. Picture: Getty Images ...

Chief executive Emma Walmsley said: “GSK delivered another year of excellent performance in 2024, with strong sales and core profit growth driven by accelerating momentum of our specialty ...

While both broadly agreed with the company’s plans to spin off its consumer-health unit, they questioned whether Chief Executive Officer Emma Walmsley was the right leader for GSK. Even so, she has ...

LON:GSK opened at GBX 1,429 ($18.05) on Friday. The company has a debt-to-equity ratio of 114.64, a quick ratio of 0.73 and a current ratio of 0.81. The firm has a market cap of £57.99 billion ...